Sernova Biotherapeutics (HAM:PSH0) Net Margin %: 0.00% (As of Apr. 2026)


HAM:PSH0 Sernova Biotherapeutics Inc HAM:PSH0
28 GF Score
Price €0.05
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Net Margin %?

Sernova Biotherapeutics HAM:PSH0 -22.00% 28 Net Margin % is 0.00% as of Apr. 2026. GuruFocus rates HAM:PSH0 with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Sernova Biotherapeutics ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Sernova Biotherapeutics's Net Income for the three months ended in Apr. 2026 was €-2.01 Mil. Sernova Biotherapeutics's Revenue for the three months ended in Apr. 2026 was €0.00 Mil. Therefore, Sernova Biotherapeutics's net margin for the quarter that ended in Apr. 2026 was 0.00%.

The historical rank and industry rank for Sernova Biotherapeutics's Net Margin % or its related term are showing as below:


HAM:PSH0's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Sernova Biotherapeutics  (HAM:PSH0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Sernova Biotherapeutics Net Margin % Related Terms


Sernova Biotherapeutics Net Margin % Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Net Margin % Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HAM:PSH0 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, Sernova Biotherapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Net Margin % falls into.


HAM:PSH0
28GF Score
Sernova Biotherapeutics Inc HAM:PSH0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Sernova Biotherapeutics's Net Margin for the fiscal year that ended in Oct. 2025 is calculated as

Net Margin=Net Income (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-9.668/0
= %

Sernova Biotherapeutics's Net Margin for the quarter that ended in Apr. 2026 is calculated as

Net Margin=Net Income (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-2.007/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Sernova Biotherapeutics (HAM:PSH0) has a Net Margin % of 0.00% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Sernova Biotherapeutics and its competitors. According to the industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 946 companies in the Biotechnology industry.
Is Sernova Biotherapeutics' Net Margin % too high?
Sernova Biotherapeutics' current Net Margin % is 0.00%. Based on the distribution chart, Sernova Biotherapeutics ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sernova Biotherapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sernova Biotherapeutics ranks #999999 out of 946 companies for Net Margin %. This places Sernova Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (HAM:PSH0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Sernova Biotherapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Sernova Biotherapeutics (HAM:PSH0), the current Net Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
28GF Score

Get the complete analysis for HAM:PSH0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price